Source: Virtual Congress 2020 – Tuberculosis and comorbidities
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
G. Musteikiene (Kaunas, Lithuania), S. Miliauskas (Kaunas, Lithuania), J. Zaveckiene (Kaunas, Lithuania), D. Urboniene (Kaunas, Lithuania), A. Vitkauskiene (Kaunas, Lithuania), M. Žemaitis (Kaunas, Lithuania), A. Naudziunas (Kaunas, Lithuania). Dynamics of inflammation biomarkers in drug sensitive tuberculosis and pneumonia. 486

Member's Comments

No comment yet.

Related content which might interest you: Differences in inflammation biomarkers among COVID-19 and Non-COVID-19 pneumonia. Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021 Estimation of inflammatory process activity in community-acquired pneumonia Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010 Studying lung inflammatory biomarkers using non-invasive methods in patients with community acquired pneumonia (CAP) Source: Eur Respir J 2002; 20: Suppl. 38, 443s Year: 2002 Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011 Dynamics of morphological changes at multi drug resistant experimental lung tuberculosis Source: Eur Respir J 2007; 30: Suppl. 51, 663s Year: 2007 Paradoxical reactions in non-HIV tuberculosis presenting as endobronchial obstruction Source: Eur Respir Rev 2009; 18: 295-299 Year: 2009 Influence of antibiotic pre-treatment on inflammatory markers in community-acquired pneumonia Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia Year: 2008 Is Neutrophil-lymphocyte ratio useful for differential diagnosis between pulmonary tuberculosis and bacterial community-acquired pneumonia. Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection Year: 2018 Method of treatment of destructive tuberculosis of single lung with extensively drug resistant mycobacteria tuberculosis Source: Annual Congress 2011 - Extrapulmonary tuberculosis and surgical interventions Year: 2011 Biomarkers of systemic inflammatory response in patients with tuberculosis, combined with HIV infection Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016 Comparison of inflammatory response biomarkers to predict complications in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Serum lipids as biomarkers for therapeutic monitoring of latent tuberculosis infection Source: Eur Respir J 2013; 42: 547-550 Year: 2013 Pharmacokinetics of drugs for non tuberculous mycobacterial lung infections Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 Multiple cytokine response to mycobacterium tuberculosis with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Frequently used inflammation markers and their role in monitoring tuberculosis treatment Source: Annual Congress 2008 - Diagnosis of tuberculosis: problems and perspectives Year: 2008 Initial and persistent inflammatory response in treatment failure in community-acquired pneumonia Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007 Accidental detection of mycobacterium tuberculosis infection in patients with various respiratory diseases Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control Year: 2008 Monitoring of drug resistance of TB mycobacteria in new pulmonary TB patients Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010 Accuracy of inflammatory markers to distinguish between pneumonia and pulmonary embolism in acute settings Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots Year: 2015 Utility of Th1-cell immune responses in differentiating active tuberculosis from latent tuberculosis infection Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014